Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.
about
CXCR4 signaling mediates morphine-induced tactile hyperalgesia.Opioids and Viral Infections: A Double-Edged SwordInteraction of drugs of abuse and microRNA with HIV: a brief reviewHeroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individualsModeling the Effects of Morphine on Simian Immunodeficiency Virus DynamicsMorphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neuronsExpression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat modelMorphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.Nociceptin/orphanin FQ receptor-driven heterologous desensitization of the major HIV-1 co-receptor CXCR4.Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activityOpioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.HIV-1 gp120 and drugs of abuse: interactions in the central nervous systemRelationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol geneMorphine suppresses IFN signaling pathway and enhances AIDS virus infection.Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs?Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytesHIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse.Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.Transcriptional regulation of the major HIV-1 coreceptor, CXCR4, by the kappa opioid receptorMorphine enhances Tat-induced activation in murine microglia.Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses.Opioids and the immune system: what is their mechanism of action?Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposureMorphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.Morphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophagesInteractive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder.Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment.Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages.Rodent models of HAND and drug abuse: exogenous administration of viral protein(s) and cocaine.Morphine and microRNA Activity: Is There a Relation with Addiction?Mechanism(s) involved in opioid drug abuse modulation of HAND
P2860
Q24624133-E1A2CFBF-5B57-4525-A299-CAE46818984EQ26742182-D2C5F260-2243-4A9D-A5AE-CA414B4090D1Q26781552-3ABBFD2A-7241-46BD-BF58-89AB0198F7A6Q28545281-4BFF91C9-343A-47E3-A636-B65073B198D3Q28554352-4F0D7577-2D30-4A4D-9041-2BF3D1108EDDQ28566402-DA4A862A-E347-4A4F-950A-9719450B5FB1Q28569735-A69E1D23-A46E-4BC0-A72F-B2B295D117B1Q28570764-A16E0039-EA05-4E79-BEBE-419202C5D913Q30569766-3CC0BC91-30EE-4960-8B8E-F91B061EA375Q33570773-BB79B261-CA22-4D32-AFFC-5369939E8012Q33817905-AA324F1E-818E-44B6-9770-7D96390ACB73Q33842214-CAD49A8F-9A4A-4A70-8608-B3CAB4563089Q33861553-00630ABA-2089-44EF-B3BC-827F21EAF2B0Q34118276-E53E020B-B02E-4299-9152-92737AEBE008Q34168153-4670A8F8-54EC-4845-B426-E35864B784D5Q34270396-5E524937-2595-4465-B8A6-83E2BA274D41Q34436453-05929EB0-4EB7-4311-AC36-705D1C9E784FQ34756351-60780381-41FE-462D-ABDC-EFCF43B7D50EQ34990993-D3E2034A-FB37-4998-91AF-51AAD052820BQ35000656-B050AA76-4011-4E24-B710-88C5E83EA4E2Q35007339-06F642B1-5151-48CD-B0FD-41366797028CQ35019404-04856E97-4BD4-475C-97CF-0AD29B369EB9Q35044062-71BFB3FB-785A-4CC4-AF7B-DC8BC773BAF8Q35063629-9A836B66-045A-4AC9-BCA1-A3F22A18719BQ35081725-156A7772-B5AE-409F-9956-6F29DE3D8668Q35177355-8922BF6B-E474-45B7-9FC5-448F62391713Q35220086-72AFADFC-B6EE-4119-B422-94A0F676752FQ35528967-C175447F-20BD-4262-8A9E-AD95738BF9E9Q35531310-BA92E35B-7973-4BF7-91F4-8DB06322A07CQ35636094-721148DC-8441-4A26-9328-5A4C8507965CQ35814647-1A29AF40-261C-4B3B-9BA8-3D768C0B4D73Q35818267-00061680-027C-4DAD-BA0C-F4E840BEEDC2Q35857045-0B77DA2C-44AC-4FBC-B8BA-E070FE55220EQ35911433-BA35F0C3-D35B-42DB-8001-5BD40E802188Q35996523-B980B714-C0CC-4EF5-A910-29E70F59B485Q36153919-C50EC3EE-B251-4780-9496-77E919337031Q36245718-35D2D3E6-90E4-4416-AA3C-2960C6628D8AQ36358486-2B6992A3-2F26-4ADC-AEF1-27A3FDB1E991Q36386234-A9926864-3A05-48D3-BE95-81805B645827Q36590733-53AB8680-9738-4B41-BE53-7D2F907B022B
P2860
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.
@en
type
label
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.
@en
prefLabel
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.
@en
P2093
P1433
P1476
Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.
@en
P2093
Amber D Steele
Earl E Henderson
Thomas J Rogers
P304
P356
10.1016/S0042-6822(03)00015-1
P407
P577
2003-04-01T00:00:00Z